Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

FDA Approves New Drug Combo for Tough-to-Treat Ovarian Cancer

FDA Approves New Drug Combo for Tough-to-Treat Ovarian Cancer

(MedPage Today) -- The FDA approved relacorilant (Lifyorli) in combination with nab-paclitaxel (Abraxane) for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The combination of...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement